FDA Archives | Page 2 of 2

A reverse chronological list of vaccine licensure announcements from FDA, vaccine recommendations from the Advisory Committee on Immunization Practices (ACIP) and CDC, and other resources from government sources. Use filters to narrow your search.

Vaccine Topics

General Topics

Patient Safety Honor Rolls

Official Release Repository

FDA expands licensure of Fluarix Quadrivalent (GSK) to include children 6 through 35 months of age

FDA licenses Heplisav-B (Dynavax), a new vaccine to prevent hepatitis B in adults

FDA licenses Shingrix (GSK), a new vaccine to prevent shingles in adults

FDA expands licensure of Afluria Quadrivalent (Seqirus) to include people age 5 years and older

FDA expands licensure of FluLaval Quadrivalent (GSK) to include people ages 6 through 35 months

FDA approves Flublok Quadrivalent (Protein Sciences) for use in persons 18 years and older

FDA expands licensure of Gardasil 9 to include a 2-dose regimen for individuals 9 through 14 years of age

FDA expands licensure for Prevar 13 to include people ages 18 through 49 years

FDA approves Vaxchora, a live oral vaccine to prevent cholera for adult travelers

FDA expands licensure of Trumenba MenB vaccine (Pfizer) administration to include 2-dose schedule and modification of the 3-dose schedule

FDA expands licensure of Hiberix to include children ages 6 weeks through 4 years

FDA expands Gardasil 9 licensure to include males age 16-26 years

FDA licenses Fluad, injectable influenza vaccine (adjuvanted), for people age 65 years and older

Two FDA CBER Mini-Sentinel Studies Completed on the Safety of Gardasil and Rotavirus Vaccines

Recall of Flulaval Quadrivalent

FDA approves Quadracel (DTaP-IPV vaccine; Sanofi Pasteur) for use in children age 4 through 6 years

FDA approves change in diluent storage temperature for Rotarix vaccine

FDA Approves a Second Vaccine to Prevent Serogroup B Meningococcal Disease

Our Affiliated Sites

Support Our Work

Subscribe to IZ Express